Compare G & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | G | BIRK |
|---|---|---|
| Founded | 1997 | 1774 |
| Country | Bermuda | United Kingdom |
| Employees | N/A | N/A |
| Industry | Professional Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.9B |
| IPO Year | 2007 | 2023 |
| Metric | G | BIRK |
|---|---|---|
| Price | $45.80 | $39.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 14 |
| Target Price | $51.00 | ★ $63.23 |
| AVG Volume (30 Days) | 1.1M | ★ 2.8M |
| Earning Date | 02-05-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.47% | N/A |
| EPS Growth | N/A | ★ 83.10 |
| EPS | ★ 3.10 | 2.19 |
| Revenue | ★ $5,009,342,000.00 | $2,460,904,611.00 |
| Revenue This Year | $8.47 | $14.14 |
| Revenue Next Year | $6.96 | $14.62 |
| P/E Ratio | ★ $14.90 | $18.36 |
| Revenue Growth | 7.39 | ★ 16.22 |
| 52 Week Low | $37.49 | $36.89 |
| 52 Week High | $56.76 | $62.66 |
| Indicator | G | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 45.84 | 43.21 |
| Support Level | $44.49 | $36.89 |
| Resistance Level | $46.29 | $40.53 |
| Average True Range (ATR) | 1.04 | 1.92 |
| MACD | -0.28 | -0.31 |
| Stochastic Oscillator | 32.19 | 34.27 |
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.